BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has entered into an agreement to purchase €2.1 million worth of PCR tests aimed at addressing the ongoing Bundibugyo Ebola outbreak. These open-platform diagnostic tools are intended to bolster infection detection efforts and enhance laboratory capacities amid the emergency situation. The procurement was coordinated with assistance from the European Health and Digital Executive Agency, with deliveries scheduled to commence in August, providing vital diagnostic resources as health authorities respond to increasing case numbers in the Democratic Republic of the Congo.
The PCR testing kits will be sent to the World Health Organization’s Hub for Global Health Emergencies Logistics located in Dubai. WHO will oversee the distribution to regions actively involved in the Ebola response. PCR testing is integral in confirming infections due to its ability to process large sample volumes with high precision, and it is compatible with existing laboratory setups. Rapid diagnosis allows health teams to promptly identify infected individuals, arrange suitable care and isolation, and support contact tracing efforts around confirmed cases.
This latest procurement builds on a separate European Commission agreement for €2.5 million worth of rapid molecular point-of-care tests and testing devices, which will be directed to the Africa Centres for Disease Control and Prevention. Collectively, these two agreements bring the total diagnostic support from the European Commission to €4.6 million. These initiatives are part of a broader European response to the Bundibugyo virus emergency, which has increasingly strained health systems in affected regions of Central and East Africa.
Diagnostic capabilities expand amid escalating outbreak
By August 12, WHO had reported 4,665 confirmed cases and 2,184 deaths in the Democratic Republic of the Congo, with cases spreading across 54 health zones in six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. The agency characterized this outbreak as the largest Ebola incident ever recorded in the country, emphasizing that transmission remained intense, facilitated by interconnected geographic clusters that contributed to ongoing spread within affected areas.
On August 14, WHO maintained its highest national risk assessment for the Democratic Republic of the Congo, rating the regional risk for neighboring nations as high and for other countries as low. Following its second meeting of the International Health Regulations Emergency Committee on August 24, WHO issued updated temporary guidelines focused on surveillance, case detection, infection prevention, clinical management, community engagement, and measures related to domestic mobility and mass gatherings.
European support now totals €493 million to combat the outbreak
The European Commission announced it has mobilized €493 million in emergency assistance, vaccines, treatments, and health-security measures across the Great Lakes and Uganda region. European health agencies have also contributed to surveillance, laboratory testing, and preparedness activities during the crisis. According to the European Centre for Disease Prevention and Control, the risk to populations in Europe remains very low, based on assessments that highlight the necessity of direct contact with infectious body fluids and the low probability of sustained transmission on the continent.
The Bundibugyo outbreak is still classified as a public health emergency of international concern, a designation declared by WHO on May 17. Unlike the more commonly encountered Zaire ebolavirus, no approved vaccine or specific treatment exists for Bundibugyo virus at present. WHO continues to stress the importance of surveillance, rapid diagnosis, patient isolation, clinical care, infection control, and contact monitoring as core components of the response. The latest PCR procurement by the European Commission strengthens laboratory capacity for these efforts, as WHO and Africa CDC coordinate health operations with national authorities in affected and neighboring countries.